RPRX
Royalty Pharma Plc
NASDAQ · Healthcare · Biotechnology · US
$67.30
−0.40%Leverage
- Debt / equity
- 1.26x
- Net debt / equity
- 1.18x
- Debt / assets
- 0.44x
- Debt / EBITDA
- 5.55x
- Net debt / EBITDA
- 5.22x
Liquidity & coverage
- Current ratio
- 1.29x
- Quick ratio
- 1.29x
- Cash ratio
- 0.46x
- Interest coverage
- 4.21x
- EBITDA / interest
- 4.17x
- Working capital
- $346.6M
Cash & dividend
- FCF / debt
- 0.34x
- Cash flow / debt
- 0.34x
- Dividend per share
- $0.92
- Dividend yield
- 1.4%
- Dividend growth 1y
- +4.8%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026